Tylosin

Tylosin is a lipid of Polyketides (PK) class. Tylosin is associated with abnormalities such as Mastitis, Bovine, Infection, Bacterial Infections, Arthritis and Ileitis. The involved functions are known as Anabolism, acireductone dioxygenase [iron(II)-requiring] activity, Protein Biosynthesis, Mastitis and Methylation. Tylosin often locates in Ribosomes, Cell Wall, 50S ribosomal subunit, Ribosome Subunits, Large and Ribosome Subunits. The associated genes with Tylosin are Gene Clusters, Genome, resistance genes, Homologous Gene and HM13 gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Tylosin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tylosin?

Tylosin is suspected in Porcine ulcerative spirochetosis, Infection, Liver Abscess, Respiration Disorders, Intestinal Diseases, Mastitis, Bovine and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tylosin

MeSH term MeSH ID Detail
Digital Dermatitis D058066 3 associated lipids
Bovine Respiratory Disease Complex D048090 2 associated lipids
Pneumonia of Calves, Enzootic D048089 2 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Pneumonia of Swine, Mycoplasmal D045729 2 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Primate Diseases D018419 2 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Per page 10 20 50 | Total 47

PubChem Associated disorders and diseases

What pathways are associated with Tylosin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tylosin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tylosin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tylosin?

There are no associated biomedical information in the current reference collection.

What genes are associated with Tylosin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tylosin?

Knock-out

Knock-out are used in the study 'A second tylosin resistance determinant, Erm B, in Arcanobacterium pyogenes.' (Jost BH et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tylosin

Download all related citations
Per page 10 20 50 100 | Total 931
Authors Title Published Journal PubMed Link
Tang L et al. Amino acid catabolism and antibiotic synthesis: valine is a source of precursors for macrolide biosynthesis in Streptomyces ambofaciens and Streptomyces fradiae. 1994 J. Bacteriol. pmid:7928973
Hue KK and Bechhofer DH Effect of ermC leader region mutations on induced mRNA stability. 1991 J. Bacteriol. pmid:1711026
Oh TG et al. Induction of ermAMR from a clinical strain of Enterococcus faecalis by 16-membered-ring macrolide antibiotics. 1998 J. Bacteriol. pmid:9791136
Zalacain M and Cundliffe E Methylation of 23S rRNA caused by tlrA (ermSF), a tylosin resistance determinant from Streptomyces fradiae. 1989 J. Bacteriol. pmid:2753855
Riddell KP et al. Antibiotic treatment of bovine embryos. 1993 J. Assist. Reprod. Genet. pmid:8069094
Poole TL et al. Effect of subtherapeutic concentrations of tylosin on the inhibitory stringency of a mixed anaerobe continuous-flow culture of chicken microflora against Escherichia coli O157:H7. 2003 J. Appl. Microbiol. pmid:12492926
Amachawadi RG et al. Effects of in-feed copper and tylosin supplementations on copper and antimicrobial resistance in faecal enterococci of feedlot cattle. 2015 J. Appl. Microbiol. pmid:25739516
Kalmokoff M et al. Continuous feeding of antimicrobial growth promoters to commercial swine during the growing/finishing phase does not modify faecal community erythromycin resistance or community structure. 2011 J. Appl. Microbiol. pmid:21395944
Logue CM et al. Repeated therapeutic dosing selects macrolide-resistant Campylobacter spp. in a turkey facility. 2010 J. Appl. Microbiol. pmid:20497488
Wardlaw AC et al. Bactericidal activity in the pig roundworm Ascaris suum. 1994 J. Appl. Bacteriol. pmid:8144403
Kaukas A et al. The effect of ampicillin and tylosin on the faecal enterococci of healthy young chickens. 1987 J. Appl. Bacteriol. pmid:3112089
Chuard C et al. In-vitro and in-vivo evaluation of the antistaphylococcal activity of S-5556, a new 16-membered macrolide. 1992 J. Antimicrob. Chemother. pmid:1452498
Lüthje P and Schwarz S Molecular analysis of constitutively expressed erm(C) genes selected in vitro in the presence of the non-inducers pirlimycin, spiramycin and tylosin. 2007 J. Antimicrob. Chemother. pmid:17085767
Buß M et al. Quality control ranges for tylosin 30 μg and 15 μg discs applicable to Staphylococcus aureus ATCC(R) 25923. 2014 J. Antimicrob. Chemother. pmid:23928021
Tejedor F and Ballesta JP Components of the macrolide binding site on the ribosome. 1985 J. Antimicrob. Chemother. pmid:4055551
Creemer LC et al. Synthesis and in vitro antimicrobial activity of 3-keto 16-membered macrolides derived from tylosin. 2002 J. Antibiot. pmid:12061552
Narandja A et al. Structure-activity relationship among polyhydro derivatives of tylosin. 1994 J. Antibiot. pmid:8040056
Mandić Z et al. New derivatives of tylosin: chemical and electrochemical oxidation products of desmycosin. 2002 J. Antibiot. pmid:12458770
Bobillot S et al. Chemical modification of tylosin. 1995 J. Antibiot. pmid:7649866
Creemer LC et al. Synthesis, antimicrobial activity and in vivo fluorine NMR of a hexafluorinated derivative of tilmicosin. 1995 J. Antibiot. pmid:7649867
Narandja A et al. 10,11,12,13-Tetrahydro derivatives of tylosin. II. Synthesis, antibacterial activity and tissue of 4'-deoxy-10,11,12,13-tetrahydrodesmycosin. 1995 J. Antibiot. pmid:7730160
Omura S et al. Ammonium ions suppress the amino acid metabolism involved in the biosynthesis of protylonolide in a mutant of Streptomyces fradiae. 1984 J. Antibiot. pmid:6511663
Arisawa A et al. Direct fermentative production of acyltylosins by genetically-engineered strains of Streptomyces fradiae. 1996 J. Antibiot. pmid:8641997
Kageyama S and Tsuchiya T Synthesis of 2-C-methyl derivatives of 3,4'-dideoxymycaminosyltylonolide, a novel type of 16-membered macrolide antibiotic. 1994 J. Antibiot. pmid:7928687
Terui Y et al. Synthesis of 2-methyl 16-membered macrolide derived from tylosin. 2006 J. Antibiot. pmid:16629410
Baltz RH et al. Biosynthesis of the macrolide antibiotic tylosin. A preferred pathway from tylactone to tylosin. 1983 J. Antibiot. pmid:6833128
Omura S et al. Chimeramycins: new macrolide antibiotics produced by hybrid biosynthesis. 1983 J. Antibiot. pmid:6860432
Tsuchiya M et al. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus. 1982 J. Antibiot. pmid:7118723
Sadakane N et al. Hybrid biosynthesis of derivatives of protylonolide and M-4365 by macrolide-producing microorganisms. 1982 J. Antibiot. pmid:7118724
Sugawara A et al. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity. 2017 J. Antibiot. pmid:28559578
Sakamoto S et al. Syntheses of 23-deoxy-23-N-ethyl-23-(2-fluoro-, 2,2-difluoro-, and 2,2,2-trifluoroethyl)amino derivatives of mycaminosyl tylonolide and 4'-deoxymycaminosyl tylonolide. 1984 J. Antibiot. pmid:6526731
Mutoh Y et al. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. II. Chemical deepoxidation by dissolving metal reduction. 1984 J. Antibiot. pmid:6706848
Sakamoto M et al. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. III. In vitro and in vivo evaluation of deepoxidation products of carbomycin A, deltamycin A1, 4"-phenylacetyldeltamycin, angolamycin and rosamicin. 1984 J. Antibiot. pmid:6706849
Omura S et al. Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds. 1983 J. Antibiot. pmid:6662812
Matsubara H et al. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin. 1983 J. Antibiot. pmid:6662813
Tanaka Y et al. Mechanism of nitrogen regulation of protylonolide biosynthesis in Streptomyces fradiae. 1986 J. Antibiot. pmid:3733529
Omura S et al. Ammonium ion suppresses the biosynthesis of tylosin aglycone by interference with valine catabolism in Streptomyces fradiae. 1983 J. Antibiot. pmid:6662823
Park JW et al. Generation of reduced macrolide analogs by regio-specific biotransformation. 2011 J. Antibiot. pmid:21102594
Lee BK et al. Multistep bioconversion of 20-deoxo-20-dihydro-12,13-deepoxy-12,13-dehydrorosaranolide to 22-hydroxy-23-O-mycinosyl-20-deoxo-20-dihydro-12,13-deepoxy-rosaramicin. 1983 J. Antibiot. pmid:6874596
Sadakane N et al. Hybrid biosynthesis of a new macrolide antibiotic by a daunomycin-producing microorganism. 1983 J. Antibiot. pmid:6885644
Norcia LJ et al. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use. 1998 J. Antibiot. pmid:9544934
Fujiwara T et al. Absorption, tissue distribution and excretion of 19-deformyldesmycosin derivatives, new 16-membered macrolides, in mice. 1990 J. Antibiot. pmid:2324015
Debono M et al. Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives. 1989 J. Antibiot. pmid:2668243
Kirst HA et al. Structure-activity studies of 20-deoxo-20-amino derivatives of tylosin-related macrolides. 1989 J. Antibiot. pmid:2684947
Naranda A and Lopotar N New derivatives of tylosin. IV. Dihydro and tetrahydro desmycosin oximes. 1999 J. Antibiot. pmid:10092201
Butler AR et al. Influence of ancillary genes, encoding aspects of methionine metabolism, on tylosin biosynthesis in Streptomyces fradiae. 2001 J. Antibiot. pmid:11594346
Tsuzuki K et al. Syntheses and antimicrobial activities of 9-O-acyl derivatives of tylosin and demycarosyltylosin. 1986 J. Antibiot. pmid:3818453
Kirst HA et al. In vitro and in vivo evaluation of C-20- and C-23-modified derivatives of tylosin against veterinary pathogens. 1988 J. Antibiot. pmid:3417566
Baltz RH and Stonesifer J Phenotypic changes associated with loss of expression of tylosin biosynthesis and resistance genes in Streptomyces fradiae. 1985 J. Antibiot. pmid:4066505
Hranjec M et al. New amidino-benzimidazolyl derivatives of tylosin and desmycosin. 2002 J. Antibiot. pmid:12014447